Highlighting healthcare innovation in the West Midlands

Representatives from NHS England and NHS Improvement attended a two-day event, hosted by BHP member the West Midlands Academic Health Science Network (WMAHSN), at iCentrum Birmingham Innovation Campus, on 27 and 28 June. The aim of the event was to showcase how the WMAHSN is transforming health and social care through innovation – supporting health … Continue reading “Highlighting healthcare innovation in the West Midlands”

The BHP Starter Fellowship – Pip’s story

Pip Nicholson is a clinical lecturer in haematology at BHP founder-member the University of Birmingham, and completed his BHP Starter Fellowship between 2015 and 2016. His research is currently focused on translating tyrosine kinase inhibitors to be used as anti-platelet drugs, and investigating the mechanisms of vaccine-induced thrombocytopaenia with thrombosis. He holds research grants from … Continue reading “The BHP Starter Fellowship – Pip’s story”

BHP launches Seed Fund to invest in innovation

Today (20 June) Birmingham Health Partners officially launches its BHP Seed Fund – a new initiative which will kick-start innovation by providing researchers with up to £100,000 initial investment. Designed to support our culture of research-embedded healthcare practice while simultaneously addressing common challenges across our member organisations, the Seed Fund will bring together healthcare professionals, … Continue reading “BHP launches Seed Fund to invest in innovation”

New funding project launched to support health and social care initiatives in the West Midlands

BHP member the West Midlands Academic Health Science Network (WMAHSN) has announced the launch of a new Human Factors Workforce Fund to support the spread or adoption of a Human Factors innovation or improvement. The fund aims to bring about tangible enhancements to workforce practices or patient experience within the region. Individuals and teams working … Continue reading “New funding project launched to support health and social care initiatives in the West Midlands”

‘Cellular brake’ offers clue to autoimmune response during immunotherapy

A ‘cellular brake’ which could prevent lung cancer patients from developing a dangerous autoimmune response during treatment has been identified by scientists. The finding, published in Nature Communications, is the first clue to the cause of autoimmune toxicity, in which patients develop dangerous additional conditions during immunotherapy treatment. Immunotherapy works by enabling the body’s immune cells (T … Continue reading “‘Cellular brake’ offers clue to autoimmune response during immunotherapy”